Signals of Change: How Biomarkers Are Reshaping Oncology and Healthcare Delivery
Biomarkers are crucial for confirming diagnoses, predicting disease progression, and tailoring therapeutic modalities, with recent research focusing on ‘omics’ technologies such as genomics, proteomics, and metabolomics.
Cancer, a leading cause of global mortality, necessitates advancements in diagnostic and therapeutic strategies, with cancer biomarkers playing a vital role in modern oncology as biological molecules indicating cancer presence, progression, or behavior.
A recent editorial in Cancers provided a review of progress in cancer biomarker development, exploring emerging innovations that are driving oncology towards a more proactive, personalized, and economically sound approach.
Recent research focuses on the ‘omics’ technologies — genomics, proteomics, metabolomics.
- Genomics
- Proteomics
- Metabolomics
Author summary: Biomarkers reshape oncology.